High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.

Source:http://linkedlifedata.com/resource/pubmed/id/3542208

Download in:

View as

General Info

PMID
3542208